Association of retinol binding protein 4 with risk of gestational diabetes

Diabetes Research and Clinical Practice

Volumn 99, Issue 1, 2013, Pages 48-53

  Abetew, Dejene F ^a   Qiu, Chunfang ^a   Fida, Neway G ^a,b   Dishi, Michal ^a   Hevner, Karin ^a   Williams, Michelle A ^a,c   Enquobahrie, Daniel A ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Gestational diabetes; Maternal age; Pregnancy; Retinol binding protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FAMILY HISTORY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; UP-REGULATION; WASHINGTON;

EID: 84870999045     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.10.023     Document Type: Article

References (34)

1. Ferrara A., Kahn H.S., Quesenberry C.P., Riley C., Hedderson M.M. An increase in the incidence of gestational diabetes mellitus. Obstet Gynecol 2004, 103:526-533.
2. Klein K., Bancher-Todesca D., Leipold H., Knöfler M., Haslinger P., Handisurya A., Kautzky-Willer A., Worda C. Retinol-binding protein 4 in patients with gestational diabetes mellitus. J Womens Health (Larchmt) 2010, 19:517-521.
3. Lawrence J.M., Contreras R., Chen W., Sacks D.A. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008, 31:899-904.
4. Mazaki-Tovi S., Romero R., Vaisbuch E., Kusanovic J.P., Chaiworapongsa T., Kim S.K., Mittal P., Dong Z., Pacora P., Yeo L., Hassan S.S. Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med 2010, 38:147-155.
5. Chan T.F., Chen H.S., Chen Y.C., Lee C.H., Chou F.H., Chen I.J., Chen S.Y., Jong S.B., Tsai E.M. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 2007, 14:169-174.
6. Krzyzanowska K., Zemany L., Krugluger W., Schernthaner G.H., Mittermayer F., Schnack C., Rahman R., Brix J., Kahn B.B., Schernthaner G. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008, 51:1115-1122.
7. Maghbooli Z., Hossein- Nezhad A., Mirzaei K., Karimi F., Besharati A., Omidfar K., Larijani B. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and the risk of developing metabolic syndrome after pregnancy. Reprod Sci 2010, 17:196-201.
8. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 2012, 76:2-11.
9. Hedderson M.M., Ferrara A., Sacks D.A. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003, 102:850-856.
10. Cho Y.M., Youn B.S., Lee H., Lee N., Min S.S., Kwak S.H., Lee H.K., Park K.S. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006, 29:2457-2461.
11. Choi S.H., Kwak S.H., Youn B.S., Lim S., Park Y.J., Lee H., Lee N., Cho Y.M., Lee H.K., Kim Y.B., Park K.S., Jang H.C. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008, 93:3142-3148.
12. Masuyama H., Inoue S., Hiramatsu Y. Retinol-binding protein 4 and insulin resistance in preeclampsia. Endocr J 2011, 58:47-53.
13. Ost A., Danielsson A., Lidén M., Eriksson U., Nystrom F.H., Strålfors P. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007, 21:3696-3704.
14. Shangguan X., Liu F., Wang H., He J., Dong M. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta 2009, 407:58-61.
15. Von Eynatten M., Lepper P.M., Liu D., Lang K., Baumann M., Nawroth P.P., Bierhaus A., Dugi K.A., Heemann U., Allolio B., Humpert P.M. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007, 50:1930-1937.
16. Kotnik P., Fischer-Posovszky P., Wabitsch M. RBP4: a controversial adipokine. Eur J Endocrinol 2011, 165:703-711.
17. Esteve E., Ricart W., Fernandez-Real J.M. Adipocytokines and insulin resistance. Diabetes Care 2009, 32:S362-S367.
18. Tepper B.J., Kim Y.K., Shete V., Shabrova E., Quadro L. Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem 2010, 43:320-323.
19. Vaisbuch E., Romero R., Mazaki-Tovi S., Erez O., Kim S.K., Chaiworapongsa T., Gotsch F., Than N.G., Dong Z., Pacora P., Lamont R., Yeo L., Hassan S.S., Kusanovic J.P. Retinol binding protein 4-a novel association with early-onset preeclampsia. J Perinat Med 2010, 38:129-139.
20. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 2007, 65:251-256.
21. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., Kotani K., Quadro L., Kahn B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
22. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., Wason C.J., Oberbach A., Jansson P.A., Smith U., Kahn B.B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563.
23. Su Y.X., Hong J., Yan Q., Xu C., Gu W.Q., Zhang Y.F., Shen C.F., Chi Z.N., Dai M., Xu M., Zhang Y.W., Liu Q.R., Li X.Y., Ning G., Wang W.Q. Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab 2010, 36:470-475.
24. Gavi S., Stuart L.M., Kelly P., Melendez M.M., Mynarcik D.C., Gelato M.C., McNurlan M.A. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007, 92:1886-1890.
25. Lewandowski K.C., Stojanovic N., Bienkiewicz M., Tan B.K., Prelevic G.M., Press M., Tuck S., O'Hare P.J., Randeva H.S. Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008, 24:300-305.
26. Abetew D.F., Enquobahrie D.A., Dishi M., Rudra C.B., Miller R.S., Williams M.A. Age at menarche, menstrual characteristics, and risk of preeclampsia. ISRN Obstet Gynecol. 2011, Epub 2011. http://dx.doi.org/10.5402/2011/472083.
27. Dishi M., Enquobahrie D.A., Abetew D.F., Qiu C., Rudra C.B., Williams M.A. Age at menarche, menstrual cycle characteristics and risk of gestational diabetes. Diabetes Res Clin Pract 2011, 93:437-442.
28. Enquobahrie D.A., Qiu C.F., Hevner K., Abetew D., Williams M.A. Maternal plasma protein profiles in response to oral 50-gram glucose load in mid-pregnancy: a pilot study. Int J Mol Epidemiol Genet 2011, 30:292-299.
29. Qiu C., Hevner K., Abetew D., Enquobahrie D.A., Williams M.A. Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus. Clin Biochem 2011, 44:804-808.
30. ADA Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
31. Hastie T.J., Tibshirani R.J. Generalized additive models 1990, Chapman-Hall, London.
32. Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007, 92:2712-2719.
33. Virjee S., Robinson S., Johnston D.G. Screening for diabetes in pregnancy. J R Soc Med 2001, 94:502-509.
34. Gavi S., Qurashi S., Stuart L.M., Lau R., Melendez M.M., Mynarcik D.C., Mcnurlan M.A., Gelato M.C. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity 2008, 16:893-895.